Alcon Inc. ALC recently received the FDA's 510(k) clearance for its Unity Vitreoretinal Cataract System (VCS) and Unity Cataract System (CS). Both the systems will be introduced from Alcon's Unity ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY ® Vitreoretinal Cataract System (VCS) and UNITY ® ...

“The idea behind the UNITY platform is to develop clinic-based and operating room equipment solutions with a seamless user experience that improve surgical workflows,” said Ian Bell, SVP and Chief ...

I reiterate a 'Strong Buy' rating for Alcon with a one-year price target of $115 per share, driven by new product pipelines and FDA clearances. Alcon's Unity VCS/CS systems received FDA clearance, set ...

UNITY® CS, part of Alcon’s award-winning UNITY® platform, is now available in Canada Significant reductions in energy* delivered into the eye were observed with UNITY® VCS compared to CENTURION® with ...

“Today marks an important day for Canadian ophthalmologists as we introduce the next generation of equipment solutions in cataract and vitreoretinal surgery, and we are grateful to those who helped us ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Alcon’s Unity combined vitreoretinal cataract system and stand-alone ...

New Delhi: Alcon has unveiled its much-anticipated UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) in India, marking what company leaders describe as not just another product ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...